Menu
Menu

Home

Archive

Reset Password

Log in
Subscribe

Insights for UK biotech CEOs,
from Mark Beards, back in the trenches

What I wish someone had told me about fundraising, governance, and the decisions that actually kill biotech companies.
From a fellow CEO who's raised £40M+, watched companies fail, and is still in the arena.

The conversations biotech CEOs need to have but rarely do

Most biotech content is written by journalists, consultants, or people who've never sat in your chair.
This is different. I'm currently raising a Series A at Santero Therapeutics.

I've built companies, served on boards, and watched governance failures destroy ventures with good science.
I write about what I've learned: the hard way.

No corporate speak. No recycled advice.
Just honest perspective from someone navigating the same challenges you are.

Latest Insights

Explore recent posts on fundraising, leadership, and building biotech companies in the UK

When the Grant Falls Through

Apr 9, 2026

•

9 min read

When the Grant Falls Through

What a Setback Reveals About Whether Your Strategy Is Real

Mark Beards
Mark Beards
Nobody Funds Science

Mar 23, 2026

•

9 min read

Nobody Funds Science

What I wish someone had told me about raising early capital, before I learned it the expensive way

Mark Beards
Mark Beards
"Focus": The Word That Kills Platform Companies

Mar 10, 2026

•

12 min read

"Focus": The Word That Kills Platform Companies

How the biotech industry's most trusted word became its most dangerous, and the medicines that died because of it

Mark Beards
Mark Beards